The largest database of trusted experimental protocols
> Chemicals & Drugs > Amino Acid > Interleukins

Interleukins

Interleukins: A diverse group of cytokines that play crucial roles in immune system regulation and inflammation.
These signaling proteins mediate communication between cells, promoting cell growth, differentiation, and immune responses.
Interleukins are invovled in a wide range of physiological and pathological processes, making them a key focus of biomedical research.
Leveraging PubCompare.ai's AI-driven platform can help researchers efficiently locate the most accurate and reproducible protocols from scientific literature, preprints, and patents, optimizing Interleukins research for quality and reliability.

Most cited protocols related to «Interleukins»

The original study sample size of 750 patients was determined on the basis of the primary end point of best overall response rate but was revised with the new primary end point of overall survival. We estimated that with 385 events (deaths) among a total of 500 patients randomly assigned to the ipilimumab-plus-gp100 and the gp100-alone groups, the study would have at least 90% power to detect a difference in overall survival, at a two-sided alpha level of 0.05, with the use of a log-rank test. A total of 481 events were required in all three groups (assuming that the events were distributed in a 3:1:1 ratio in the ipilimumab-plus-gp100, ipilimumab-alone, and gp100-alone groups, respectively). Therefore, all patients who were randomly assigned in the study were to be followed until at least 481 events had occurred in the study. Enrollment was completed on July 25, 2008, when more than 650 patients had been enrolled. A post hoc power analysis showed that the 219 events observed among a total of 273 patients randomly assigned to the ipilimumab-alone and gp100-alone groups provided at least 80% power to detect a difference in overall survival between the two groups, at a two-sided alpha level of 0.05, with the assumption that ipilimumab alone has the same treatment effect as the combination regimen of ipilimumab plus gp100.
Survival was defined as the time from randomization to death from any cause, and progression-free survival as the time from randomization to documented disease progression or death. Event-time distributions were estimated with the use of the Kaplan–Meier method. Cox proportional-hazards models, stratified according to metastasis status and receipt or nonreceipt of previous interleukin therapy, were used to estimate hazard ratios and to test for significance of the timing of events. All reported P values are two-sided, and confidence intervals are at the 95% level. Survival rates were based on Kaplan–Meier estimation, and confidence intervals were calculated with the use of the bootstrap method. Descriptive statistics were used for adverse events.
Publication 2010
Disease Progression Interleukins Ipilimumab Neoplasm Metastasis Patients Therapeutics Treatment Protocols
We conducted a systematic literature search in the database MEDLINE (1980–2005) to review statistical methods that have been previously applied to cytokine data. Because the objective was to get a crude overview rather than to reveal the exact number of papers published in this area we defined quite sensitive search criteria using the following key words: "cytokine$" or terms to identify specific cytokines (e.g. among others "IL$," "interleukin$," IF$, interferon$, TNF$, etc.) and common univariate and multivariate statistical techniques (e.g. among others "linear regression,""analysis of variance,""cluster analysis,""factor analysis" etc.).
Table 1 shows the results of our search. The most widely used methods found were simple statistical approaches that investigate the relationship between two variables (so called bivariate methods – also called univariate methods when variables are classified as dependent and independent variables). We frequently found standard methods to compare means of immunological parameters between independent groups (e.g. t-test, analysis of variance or their non-parametric equivalents), bivariate correlation analysis (Pearson's or Spearman's correlation coefficients) and univariate linear regression. By contrast, multivariate techniques ( i.e. statistical approaches that consider three or more study variables simultaneously) were less frequently applied to cytokine data. Several studies used factor analysis (to identify groups of correlated immunological parameters) or cluster analysis (to identify groups of individuals with similar immunological profiles) or discrimination techniques such as logistic regression, discriminant analysis (to identify causes or consequences of immunological profiles). We also found a few examples of advanced modelling techniques (path analysis/structural equation modelling) that simultaneously model multiple relationships between the study variables.
In the following section we provide an overview of statistical methods that can be considered for analysing immunological data that should help the applied immunologists without a detailed knowledge of statistics to select the appropriate statistical technique for each particular research question. The definition of which method is the most appropriate is strongly dependent on the research objective, the type of data collected, whether data assumptions are fulfilled and whether the sample size is sufficient. We begin with a short introduction to these topics.
Full text: Click here
Publication 2007
Cytokine Discrimination, Psychology Interferons Interleukins
The detection of autoantibodies against cytokines with the use of Luciferase Immunoprecipitation Systems has been reported previously.4 (link) Autoantibodies were evaluated against 41 targets: interferons γ, α1, β1, ε, λ1, λ3, and ω; interleukins 1α and 1β; the interleukin-1 receptor antagonist; interleukins 2, 3, 4, 6, 7, 8, 10, 12p35, 12p40, 15, 17A,17F, 18, 21, 22, 23p19, 27p28, 32, and 33; Epstein–Barr virus–induced gene 3 protein (interleukin-27b); granulocyte colony-stimulating factor (G-CSF); granulocyte–macrophage colony-stimulating factor (GM-CSF); TNF-α; tumor necrosis factor β; B-cell–activating factor; a proliferation inducing ligand; the Fas ligand (FasL); the CD40 ligand; erythropoietin; transforming growth factor β; and the extracellular domain of the CD4 receptor. Additional methodological details are described in the Supplementary Appendix; a detailed protocol and video describing the Luciferase Immunoprecipitation Systems technique are also included in an article by Burbelo et al.21 Anti–interferon-γ–specific autoantibody isotype and IgG subclasses were determined with the use of a particle-based assay, as described previously 22 (link); total IgG subclasses were determined with the use of the Bio-Plexisotype kit (Bio-Rad Laboratories)according to the manufacturer’s instructions. Interferon-γ–specific IgG was purified by fractionating total IgG on protein G columns (Ab SpinTrap, GE Healthcare) and applying the total IgG fraction to an interferon-γ column.
Publication 2012
Autoantibodies Biological Assay CD4 Antigens CD40 Ligand Cytokine EBI3 protein, human Erythropoietin G-substrate Granulocyte-Macrophage Colony-Stimulating Factor Granulocyte Colony-Stimulating Factor Immunoglobulin Isotypes Immunoprecipitation Interferons Interferon Type II Interleukin-2 Interleukin-4 Interleukin 1 Receptor Antagonist Protein Interleukins Ligands Luciferases Transforming Growth Factors Tumor Necrosis Factor-alpha TUMOR NECROSIS FACTOR BETA Tumor Necrosis Factor Ligand Superfamily Member 6

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2018
Cytokine Genes, vif Immune System Processes Interleukins Microbicides Receptors, Antigen, B-Cell Signal Transduction Pathways T-Cell Receptor Tumor Necrosis Factor Receptor
Total RNA was isolated from LV tissue using TRIzol reagent (Invitrogen), and cDNA was synthesized from 1 µg RNA using the iScript™ cDNA Synthesis kit (BioRad). Relative levels of mRNA transcripts for atrial natriuretic factor (ANF), connective tissue growth factor (CTGF), TNF, interleukin(IL)-1β, IL-6, IL-10, matrix metalloproteinase(MMP)-2, and MMP-9 were quantified by real-time PCR using SYBR® Green (Applied Biosystems). Data were normalized to GAPDH expression using the CT comparative method [14 (link)]. Primer pairs are listed in Supplemental Table 1.
Publication 2009
Anabolism Atrial Natriuretic Factor Connective Tissue Growth Factor DNA, Complementary GAPDH protein, human IL10 protein, human Interleukin-1 beta Interleukins Matrix Metalloproteinases MMP2 protein, human MMP9 protein, human Oligonucleotide Primers Real-Time Polymerase Chain Reaction RNA, Messenger SYBR Green I Tissues trizol

Most recents protocols related to «Interleukins»

Not available on PMC !

Example 7

Use in Patients for Treating Solid Tumours

Stored haematopoietic cells (e.g. haematopoietic stem cells or granulocyte precursor cells obtainable therefrom), and granulocytes (e.g. neutrophils) differentiated therefrom are matched to cancer patients based on their cancer type, blood type (ABO, rhesus and HLA), and/or genetics. Patients may also be matched based on human leukocyte antigen (HLA) similarity.

Patients are treated using:

    • IV infusion of haematopoietic cells (including haematopoietic stem cells, and granulocyte precursor cells) together with granulocyte-colony stimulating factor, human growth hormone, serotonin, and interleukin into the patient; or
    • IV infusion of stimulated granulocyte precursor cells (obtainable from haematopoietic stem cells) into the patient. Without wishing to be bound by theory, it is believed that said cells naturally differentiate into granulocytes (e.g. neutrophils) having a high CKA in a CKA assay in vivo; or
    • direct IV infusion of granulocytes (e.g. neutrophils) having a high CKA in a CKA assay which have been differentiated from haematopoietic cells (e.g. haematopoietic stem cells).

Typically, cells are infused once weekly for 8 weeks with a cell volume of 2×1011 administered per week. Progress of the therapy is monitored and dosing is adapted accordingly.

Full text: Click here
Patent 2024
Biological Assay Cells Granulocyte Granulocyte Colony-Stimulating Factor Granulocyte Precursor Cells Hematopoietic System Histocompatibility Antigens Class II Human Growth Hormone Interleukins Intravenous Infusion Macaca mulatta Malignant Neoplasms Neoplasms Neutrophil Patients Serotonin Stem Cells, Hematopoietic Therapeutics
A total of 14 root tendons collected from 2 to 4 weeks were subjected to histological examination, fixed in 10% formalin and embedded in paraffin. The embedded tendons were cut into 4 μm cross-sectional sections and stained with hematoxylin and eosin (HE). An independent examiner completed the histological interpretation at magnifications of ×10 and ×20 and calculated the number and density of Fibroblast (Fb) displacements. In addition, a total of 49 serum samples from 7 blood sampling sites were subjected to Enzyme-linked Immunosorbent Assay (ELISA) to test for the pro-inflammatory factor-rat interleukin IL-1β and the anti-inflammatory factor-growth transforming factor TGF-β1 by double antibody sandwich ELISA, both kits were purchased from Rexin Bio (Size 96T, sensitivity: <0.1 pg/mL, IL-1β test range: 1.25–40 pg/mL, TGF-β1 test range: 2.5–80 ng/mL). Operating procedure All reagents and components are first brought back to room temperature, standards, controls and samples, and it is recommended to do duplicate wells. The operating procedure is as follows:
1) Prepare the working solutions for the various components of the kit as described in the previous instructions. 2) Remove the required slides from the aluminium foil bag and put the remaining slides back into the refrigerator in a sealed self-sealing bag. 3) Set up the standard wells, 0-value wells, blank wells and sample wells. Add 50 μL of standard at different concentrations to each of the standard wells, 50 μL of sample diluent to the 0-value wells, and 50 μL of the sample to be tested to the blank wells. 4) Add 100 μL of Horseradish Peroxidase (HRP)-labelled detection antibody to the standard wells, 0-value wells and sample wells, except for the blank wells. 5) Cover the reaction plate with sealing film. Incubate the plate for 60 min at 37°C in a water bath or thermostat protected from light. 6) Remove the sealing film, discard the liquid, pat dry on blotting paper, fill each well with washing solution, leave for 20 s, shake off the washing solution, pat dry on blotting paper and repeat 5 times. If using an automatic plate washer, follow the operating procedures of the washer and add a 30 s soak procedure to improve the accuracy of the assay. At the end of the wash, before adding the substrate, pat the reaction plate dry on clean, non-flaking paper. 7) Mix substrate A and B in a 1:1 volume and add 100 μL of substrate mixture to all wells. Cover the plate with sealing film and incubate for 15 min at 37°C in a water bath or thermostat protected from light. 8) Add 50 μL of termination solution to all wells and read the Optical Density (OD) of each well on an enzyme marker.
Full text: Click here
Publication 2023
Aluminum Anti-Inflammatory Agents Bath Biological Assay Displacement, Psychology Enzyme-Linked Immunosorbent Assay Enzymes Eosin Fibroblasts Formalin Horseradish Peroxidase Hypersensitivity Immunoglobulins Inflammation Interleukin-1 beta Interleukins Light Paraffin Embedding Plant Roots Serum Tendons TGF-beta1 Tremor Vision
Two 3-mL blood samples were collected from the jugular vein from one pig per pen on the last day of phase 2, as well as on the last day of phase 3. An equal number of barrows and gilts were sampled within treatment, and the same pigs were sampled at each time point. Of the two samples of blood obtained per pig, one was collected in a vacutainer containing ethylenediamine-tetraacetic acid as an anticoagulant, immediately placed on ice, and analyzed for complete blood cell count on a multiparameter automated hematology analyzer (CELL-DYN 3700, Abbott Laboratories, Abbott Park, IL, USA). The second sample of blood was collected in a serum vacutainer containing spray-dried silica as a clot activator. Samples were allowed to clot and then centrifuged at 4,000 × g for 13 min at room temperature. Serum was removed from centrifuged tubes and stored at −20°C until analysis. Total protein, blood urea N, and albumin were analyzed using a Beckman Coulter Clinical Chemistry AU analyzer (Beckman Coulter Inc., Brea, CA, USA). The concentration of immunoglobulin G (IgG) in serum samples was determined by enzyme-linked immunosorbent assay following the manufacturer’s instructions (Bethyl Laboratories, Inc., Montgomery, TX, USA). Concentrations of interleukin (IL)-1α, IL-1β, IL-1 receptor antagonist (IL-1RA), IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-18, interferon-gamma (IFN-γ), and tumor necrosis factor-α in serum samples were measured via a porcine-specific multiplex immunoassay kit (MilliporeSigma, Burlington, MA, USA) and read with a Luminex MagPix instrument (Luminex Corporation, Austin, TX, USA).
Full text: Click here
Publication 2023
Albumins Anticoagulants austin BLOOD Cells Clotrimazole Complete Blood Count Edetic Acid Enzyme-Linked Immunosorbent Assay IL1A protein, human IL1B protein, human Immunoassay Immunoglobulin G Interferon Type II Interleukin-2 Interleukin-4 Interleukin-6 Interleukin-8 Interleukin-10 Interleukin-12 Interleukin-18 Interleukin 1 Receptor Antagonist Protein Interleukins Jugular Vein Pigs Proteins Serum Silicon Dioxide Specimen Handling Tumor Necrosis Factor-alpha Urea
Single nucleotide polymorphisms (SNPs) significantly (P < 5×10-8) related to VEGF levels were selected as instrumental variables (IVs). Since only 3 SNPs were retained after a harmonizing step at r2 < 0.001, all independent variants (r2 < 0.01) were retained based on European ancestry reference data from the 1000 Genomes Project. In addition, the Phenoscanner (22 (link), 23 (link)) (http://www.phenoscanner.medschl.cam.ac.uk/) search was used to check or detect whether any of these selected SNPs were strongly related to other diseases or phenotypes other than VEGF, so as to prevent a possible effect of the genetic variants on the outcome through confounding factors, known as horizontal pleiotropy. We looked up each SNP and their proxies (r2 > 0.80) to check any previous associations (P <5×10-8) with 3 potential confounders selected based on previously published studies: ulcerative colitis (24 (link)–26 (link)), interleukin (IL) levels (27 (link)–29 (link)) and hemoglobin concentration (30 (link)). Three SNPs were detected and eliminated for being associated with potential confounders (rs6920532: colitis ulcerative, rs6921438: interleukin (IL) (IL-12p70, IL-10, IL-13, IL-7 and IL-5) levels, and rs34881325: hemoglobin concentration).
Full text: Click here
Publication 2023
Colitis Europeans Genetic Diversity Genome Hemoglobin Interleukin-5 Interleukin-7 Interleukin-10 Interleukin-12 Interleukin-13 Interleukins Phenotype Single Nucleotide Polymorphism Ulcer Ulcerative Colitis Vascular Endothelial Growth Factors
Tumor necrosis factor (TNF)-α, interferon (IFN)-γ, IL-6, IL-1β, IL-17A, and IL-10 were respectively determined by RayBiotech (QAM-INT-1-1) chips (Quantibody® Mouse Interleukin Array) according to the manufacturer’s instructions.
Full text: Click here
Publication 2023
DNA Chips IL10 protein, human Interferons Interferon Type II Interleukin-1 beta Interleukin-17A Interleukins Mus TNF protein, human

Top products related to «Interleukins»

Sourced in United States, United Kingdom, Germany, Canada, France, Belgium, Switzerland, China, Austria, Sweden, Australia, Japan, Italy
The Bio-Plex 200 system is a multiplex immunoassay platform that allows for the simultaneous detection and quantification of multiple analytes in a single sample. The system utilizes fluorescently-labeled magnetic beads and a dual-laser detection system to perform high-throughput, multiplexed analyses.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in Germany, United States, United Kingdom, Netherlands, Spain, Japan, Canada, France, China, Australia, Italy, Switzerland, Sweden, Belgium, Denmark, India, Jamaica, Singapore, Poland, Lithuania, Brazil, New Zealand, Austria, Hong Kong, Portugal, Romania, Cameroon, Norway
The RNeasy Mini Kit is a laboratory equipment designed for the purification of total RNA from a variety of sample types, including animal cells, tissues, and other biological materials. The kit utilizes a silica-based membrane technology to selectively bind and isolate RNA molecules, allowing for efficient extraction and recovery of high-quality RNA.
Sourced in United States, China, Japan, Germany, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Netherlands, Belgium, Lithuania, Denmark, Singapore, New Zealand, India, Brazil, Argentina, Sweden, Norway, Austria, Poland, Finland, Israel, Hong Kong, Cameroon, Sao Tome and Principe, Macao, Taiwan, Province of China, Thailand
TRIzol reagent is a monophasic solution of phenol, guanidine isothiocyanate, and other proprietary components designed for the isolation of total RNA, DNA, and proteins from a variety of biological samples. The reagent maintains the integrity of the RNA while disrupting cells and dissolving cell components.
Sourced in United States, Germany, United Kingdom, China, Canada, France, Japan, Australia, Switzerland, Israel, Italy, Belgium, Austria, Spain, Gabon, Ireland, New Zealand, Sweden, Netherlands, Denmark, Brazil, Macao, India, Singapore, Poland, Argentina, Cameroon, Uruguay, Morocco, Panama, Colombia, Holy See (Vatican City State), Hungary, Norway, Portugal, Mexico, Thailand, Palestine, State of, Finland, Moldova, Republic of, Jamaica, Czechia
Penicillin/streptomycin is a commonly used antibiotic solution for cell culture applications. It contains a combination of penicillin and streptomycin, which are broad-spectrum antibiotics that inhibit the growth of both Gram-positive and Gram-negative bacteria.
Sourced in United States, United Kingdom, Germany, France, China, Japan, Sweden, Canada, Italy, Switzerland, Israel, Macao, Netherlands, Austria
TNF-α is a recombinant human tumor necrosis factor-alpha (TNF-α) protein. TNF-α is a key pro-inflammatory cytokine that plays a central role in the immune response and inflammatory processes.
Sourced in United States, Germany, China, Japan, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Belgium, Denmark, Netherlands, India, Ireland, Lithuania, Singapore, Sweden, Norway, Austria, Brazil, Argentina, Hungary, Sao Tome and Principe, New Zealand, Hong Kong, Cameroon, Philippines
TRIzol is a monophasic solution of phenol and guanidine isothiocyanate that is used for the isolation of total RNA from various biological samples. It is a reagent designed to facilitate the disruption of cells and the subsequent isolation of RNA.

More about "Interleukins"

Interleukins (ILs) are a diverse group of cytokines that play a crucial role in immune system regulation and inflammation.
These signaling proteins facilitate communication between cells, promoting cell growth, differentiation, and immune responses.
ILs are involved in a wide range of physiological and pathological processes, making them a key focus of biomedical research.
Leveraging the power of PubCompare.ai's AI-driven platform can help researchers efficiently locate the most accurate and reproducible protocols from scientific literature, preprints, and patents, optimizing Interleukins research for quality and reliability.
This cutting-edge technology enables researchers to identify the optimal products and procedures, enhancing the quality and reliability of their work.
The Bio-Plex 200 system is a powerful tool used in Interleukins research, allowing for the simultaneous measurement of multiple cytokines, including various Interleukins.
Fetal Bovine Serum (FBS) is often used as a cell culture supplement to support cell growth and differentiation, while the RNeasy Mini Kit and TRIzol reagent are commonly used for RNA extraction and purification in Interleukins studies.
Penicillin/streptomycin is a widely used antibiotic combination that helps prevent bacterial contamination in cell culture experiments.
Tumor Necrosis Factor-alpha (TNF-α) is an Interleukin-like cytokine that plays a crucial role in inflammation and immune responses, often studied in conjunction with Interleukins.
TRIzol, a popular reagent, is used for the isolation and purification of RNA, DNA, and proteins, including those related to Interleukins.
By leveraging the insights and tools provided by PubCompare.ai, researchers can optimize their Interleukins research, leading to more accurate and reproducible results that advance our understanding of these important signaling molecules and their role in health and disease.